Johnson & Johnson to buy Danvers-based cardiovascular technology company Abiomed in $16.6 billion deal
November 1st, 2022 | 🕒
iSpeech Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.The
Gloss